Multimedia |
CME From JCP |
JCP Supplement |
CME From PCC
MultimediaIndividuals with narcolepsy may experience not only academic, social, and occupational consequences but also dangerous driving or other accidents, meaning that effective treatment is critical. Here, review the evidence on treatment strategies. [top]
Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy
Treating Excessive Daytime Sleepiness in Patients With Narcolepsy
Thomas Roth, PhD
[Activity] [Posttest] 8/31/2022
Screening for Excessive Daytime Sleepiness and Diagnosing Narcolepsy
John W. Winkelman, MD, PhD
[Activity] [Posttest] 7/31/2022
The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery
Patient-Centered Psychopharmacology and Psychosocial Interventions: Treatment Selection and Shared Decision-Making to Enhance Chances for Recovery
John Lauriello, MD
[Activity] [Posttest] 4/30/2022
Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences
Christoph U. Correll, MD
[Activity] [Posttest] 3/31/2022
Current Treatment Options and Emerging Agents for Schizophrenia
Christoph U. Correll, MD
[Activity] [Posttest] 3/31/2022
Prevalence and Impact of Relapse in Patients With Schizophrenia
John Lauriello, MD
[Activity] [Posttest] 3/31/2022
Identifying and Treating Insomnia in Patients Living with Alzheimer’s Disease
Identifying and Treating Insomnia in Patients Living with Alzheimer’s Disease
Alon Y. Avidan, MD, MPH, and Anna D. Burke, MD
[Activity] [Posttest] 4/30/2022
Measurement-Based Care for Depression From Screening and Assessment Through Treatment
Major Depressive Disorder in Primary Care: Strategies for Identification
Madhukar H. Trivedi, MD
[Activity] [Posttest] 3/31/2022
How Can Measurement-Based Care Help Improve Treatment Outcomes for Major Depressive Disorder in Primary Care?
Madhukar H. Trivedi, MD
[Activity] [Posttest] 3/31/2022
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment
Medication Options and Clinical Strategies for Treating Tardive Dyskinesia
Leslie L. Citrome, MD, MPH
[Activity] [Posttest] 1/31/2022
Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools
Stephen R. Saklad, PharmD, BCPP
[Activity] [Posttest] 12/31/2021
Strategies for Acute and Maintenance Treatment of Bipolar I Disorder
Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder
Trisha Suppes, MD, PhD
[Activity] [Posttest] 12/31/2021
Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder
Trisha Suppes, MD, PhD
[Activity] [Posttest] 12/31/2021
Earlier Diagnosis and Expanded Treatment Options for Patients With Parkinson Disease
Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease
Stuart H. Isaacson, MD
[Activity] [Posttest] 12/31/2021
Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments
Stuart H. Isaacson, MD
[Activity] [Posttest] 12/31/2021
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia
Treatment Strategies for Tardive Dyskinesia
Daniel E. Kremens, MD, JD
[Activity] [Posttest] 11/30/2021
Earlier Diagnosis of Tardive Dyskinesia
Daniel E. Kremens, MD, JD
[Activity] [Posttest] 11/30/2021
FDA-Approved Medications to Treat Tardive Dyskinesia
Joseph P. McEvoy, MD
[Activity] [Posttest] 11/30/2021
Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia
Joseph P. McEvoy, MD
[Activity] [Posttest] 10/31/2021
A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease
A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease
Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD
[Activity] [Posttest] 8/31/2021
Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation
Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD
[Activity] [Posttest] 6/30/2021
Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication
Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD
[Activity] [Posttest] 2/28/2021
New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder
New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder
Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD
[Activity] [Posttest] 7/31/2021
Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia
Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia
John Lauriello, MD, and Diana O. Perkins, MD
[Activity] [Posttest] 3/31/2021
Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder
Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents
Melissa P. DelBello, MD, MS
[Activity] [Posttest] 12/31/2020
Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients
Manpreet K. Singh, MD, MS
[Activity] [Posttest] 12/31/2020
Current and Emerging Treatments to Address Unmet Needs in MDD
Current and Emerging Treatments to Address Unmet Needs in MDD
Michael E. Thase, MD
[Activity] [Posttest] 12/31/2020
Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder
Diagnosing Bipolar Disorder in Pediatric Patients
Kiki D. Chang, MD
[Activity] [Posttest] 1/31/2021
Treating Bipolar Disorder in Adolescents
Robert L. Findling, MD, MBA
[Activity] [Posttest] 1/31/2021
Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management
Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment
Larry Culpepper, MD, MPH
[Activity] [Posttest] 10/31/2020